What Ice Neurosystems does

iCE Neurosystems is a privately held medical technology company developing the iCEWav Platform, an integrated device-and-data ecosystem for continuous EEG (cEEG) brain monitoring in critical care settings. The platform combines three FDA-cleared and HIPAA-compliant components: iCE Electrodes, single-use subcutaneous EEG electrodes that routine clinical staff can insert at the bedside in approximately five minutes without requiring an EEG technologist; iCEWav Bedside, a plug-and-play acquisition system that time-locks brain activity with other vital signs and converts raw EEG into intuitive visualizations for real-time clinical interpretation; and iCECloud, a secure cloud platform that stores, curates, and enriches structured multimodal data for analytics and AI-based clinical decision support. The company positions its solution against the structural limitations of traditional EEG — noisy data, dependency on specialized technicians, lack of integration with other physiologic signals, and impracticality for routine clinical staff — which the company states have constrained cEEG adoption to fewer than 1% of critically ill patients.

iCE Neurosystems targets hospital systems, intensive care units, cardiac care units, stroke centers, and trauma centers, with explicit clinical use cases spanning cardiac arrest, heart failure, stroke, intracranial hemorrhage, severe trauma, and complex cardiac and neurovascular procedures. The company also markets iCECloud for tele-stroke and tele-ICU deployment, extending the platform beyond single-site bedside monitoring. Its revenue model is built on two pillars: hardware sales of FDA-cleared single-use electrodes and bedside acquisition systems (creating a recurring consumable revenue stream alongside capital equipment), and software/cloud subscription revenue from iCECloud for data management, analytics, and AI-based decision support. Go-to-market is direct enterprise field sales to healthcare institutions, with no disclosed distribution intermediaries, marketplace listings, or publicly available pricing.

The company was founded in 2017 and is headquartered in Washington, DC, with a team of 1–10 employees led by co-founders Allen Wazari (CEO), Jan Claassen, Laith Altawheel, and Ron Emerson, drawing on multidisciplinary experience in neurocritical care, advanced data science, brain-machine interface, and clinical data systems. In May 2024 iCE participated in the MedTech Innovator accelerator; no material institutional funding round or revenue figures have been disclosed in the available data.

Name

Ice Neurosystems

Legal name

iCE Neurosystems

Website

https://iceneurosystems.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

iCE Neurosystems develops the iCEWav Platform — FDA-cleared subcutaneous EEG electrodes, a bedside acquisition system, and HIPAA-compliant cloud analytics — to enable continuous brain monitoring in hospital ICUs, stroke centers, and trauma units for critically ill patients.

Ownership category

akta.pro rank

Product category

Neurological Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industry

Neurology Telemedicine Platforms (HLALAGAC)

Keywords

• Continuous EEG monitoring
• Brain monitoring devices
• Subcutaneous EEG electrodes
• Critical care neurology
• Multimodal clinical data platform

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales (Hardware): Revenue from sale of FDA-cleared single-use subcutaneous EEG electrodes (iCE Electrodes) and bedside EEG acquisition systems (iCEWav Bedside). The electrodes are described as single-use, suggesting recurring consumable revenue alongside capital equipment sales.
2. Software/Cloud Platform Subscription: iCECloud is described as a cloud-based platform providing data storage, curation, and analytics access. This suggests a SaaS/subscription component for data management, AI-based clinical decision support, and tele-stroke/tele-ICU deployment capabilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

iCE Neurosystems provides the iCEWav Platform, an integrated device and data ecosystem for continuous EEG-based brain monitoring in critical care. The platform pairs proprietary single-use subcutaneous EEG electrodes (iCE Electrodes) with an FDA-cleared bedside EEG acquisition system (iCEWav Bedside) and a HIPAA-compliant cloud analytics platform (iCECloud) that supports AI-based clinical decision support and tele-stroke/tele-ICU deployment. Together these offerings deliver continuous, high-fidelity brain data alongside the body's vital signs for use by routine clinical staff without EEG technologists.

Product overview

iCE Neurosystems offers the iCEWav Platform, a fully integrated device and data ecosystem designed to make continuous EEG-based brain monitoring practical in real-world clinical environments. The platform combines three core products: iCE Electrodes (single-use subcutaneous EEG electrodes for bedside insertion), iCEWav Bedside (an FDA-cleared EEG system that integrates brain activity with vital signs), and iCECloud (a HIPAA-compliant cloud analytics platform). Together, these components deliver continuous, high-fidelity structured brain data alongside the body's vital signs to enable automated brain monitoring during critical care.

Differentiator

Problem solved

Functional benefit

Brands

• iCEWav Platform: Fully integrated device and data ecosystem designed to make cEEG-based brain monitoring practical in real-world clinical environments, combining proprietary electrode devices, bedside multimodal data acquisition software, and cloud-based analytics.
• iCE Electrodes
• iCEWav Bedside
• iCECloud

Products and services

• iCE Electrodes

Quantifiable outcome

• cEEG monitoring currently reaches fewer than 1% of critically ill patients, indicating massive unmet need and market opportunity for a practical continuous brain monitoring solution

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves1 record

Expansion highlights4 records

Broad incumbents

• Natus Neuro (Natus Medical): Incumbent neurodiagnostics leader with the dominant installed base of clinical EEG systems, EEG electrodes, and ICU brain monitoring products. Directly overlaps iCE's cEEG-in-ICU proposition and represents the primary competitor iCE must displace in hospital accounts.
• Masimo: Major patient monitoring incumbent with growing footprint in brain and cerebral oximetry monitoring. Adjacent competitor for ICU multimodal monitoring budgets that iCE also targets.
• Medtronic (Brain Mechanisms and Intraoperative Neuromonitoring): Large medtech incumbent with intraoperative neuro-monitoring and neuroscience offerings. Compares to iCE on the neuromonitoring clinical category and as a deep-pocketed competitor for hospital capital.
• Integra LifeSciences: Neurosurgery and neuro critical care device maker selling disposables and monitoring products into the same ICU and neurosurgery channels iCE serves with its electrodes and bedside system.

Direct peers

• Compumedics: Australia-based developer of clinical EEG and long-term monitoring systems used in ICUs and sleep labs. Comparable to iCE in selling EEG hardware and software into critical care and research settings.
• Cadwell Industries: US neurodiagnostic equipment maker selling EEG systems and electrodes to hospitals and neurology practices. Closely mirrors iCE's hardware-plus-electrode commercial model in clinical neurophysiology.
• Persyst Development Corporation: Developer of EEG trending and seizure detection software used alongside clinical EEG systems in ICUs. Highly comparable to iCECloud's AI/analytics layer and often integrated with Natus-style hardware that iCE is competing against.
• Ceribell: Point-of-care brain monitoring company with FDA-cleared rapid EEG system targeted at non-EEG clinicians in ICUs and EDs. Closest direct competitor to iCE on the 'EEG made practical for routine clinical staff' thesis.

Emerging players

• Wave Neuroscience: Emerging brain monitoring and neuro-modulation company focused on EEG-based assessment and therapy. Compares to iCE in advancing practical, software-enabled EEG applications outside traditional research-grade EEG.
• Moberg ICU Solutions: Focused ICU multimodal monitoring vendor integrating EEG with other physiologic signals at the bedside. Direct conceptual overlap with iCEWav Bedside's plug-and-play, time-locked vital signs approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ice Neurosystems